Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 143

Showing 26-50 of 143 citing articles:

Rationally designed multifunctional nanoparticles as GSH-responsive anticancer drug delivery systems based on host-guest polymers derived from dextran and β-cyclodextrin
Xichuan Tang, Yuting Wen, Zhongxing Zhang, et al.
Carbohydrate Polymers (2023) Vol. 320, pp. 121207-121207
Closed Access | Times Cited: 24
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 11
A novel amino-pyrimidine inhibitor suppresses tumor growth via microtubule destabilization and Bmi-1 down-regulation
Lijie Gao, Jiawei Liu, Rui Zhang, et al.
Biochemical Pharmacology (2025), pp. 116783-116783
Closed Access
Dioscin: A review on pharmacological properties and therapeutic values
Shinjini Bandopadhyay, Uttpal Anand, Vijaykumar Shivaji Gadekar, et al.
BioFactors (2021) Vol. 48, Iss. 1, pp. 22-55
Closed Access | Times Cited: 40
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 30
Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update
Swaroop Kumar Pandey, Uttpal Anand, Waseem Ahmad Siddiqui, et al.
Advances in Medicine (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 18
The Battlefield of Chemotherapy in Pediatric Cancers
Letao Bo, Youyou Wang, Yidong Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1963-1963
Open Access | Times Cited: 16
Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study
Jiaming Gao, Jingwen Cheng, Wanyu Xie, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 639-651
Closed Access | Times Cited: 6
lncRNAs: New players of cancer drug resistance via targeting ABC transporters
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 6
Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance
Hongzheng Wang, Min Huang, Mengyuan Zhu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
From Taxus to paclitaxel: Opportunities and challenges for urban agriculture to promote human health
Xiulan Xie, Yaohua Zhai, Hao Cheng, et al.
Plant Physiology and Biochemistry (2025) Vol. 220, pp. 109502-109502
Closed Access
Establishment of a chemoresistant laryngeal cancer cell model to study chemoresistance and chemosensitization responses via transcriptomic analysis and a tumor‐on‐a‐chip platform
Christian R. Moya‐Garcia, Meghana Munipalle, Alain Pacis, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Rational design of peptides to overcome drug resistance by metabolic regulation
Min Sun, Le He, Ran Chen, et al.
Drug Resistance Updates (2025), pp. 101208-101208
Closed Access
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody
Jinguan Lin, Song Qu, Kunyu Yang, et al.
Cancer Letters (2025), pp. 217513-217513
Closed Access
Design, synthesis and anticancer evaluation of novel 1,3-imidazole-type phenylhistin derivatives: Dual mechanism via P53 induction and microtubulin inhibition
Na Chen, Bo Wang, Shihao Wang, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108271-108271
Closed Access
Investigation of the sensitivity of human A549 cells to paclitaxel and sesquiterpene lactone alantolactone via apoptosis induction
İrem BAYAR, Yalçın Erzurumlu, Senem Akkoç, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Overcoming cancer therapy resistance: From drug innovation to therapeutics
Jinrui Wei, Meng‐Yi Lu, Tian‐Hua Wei, et al.
Drug Resistance Updates (2025), pp. 101229-101229
Closed Access
Natural Taxanes: From Plant Composition to Human Pharmacology and Toxicity
Ľuboš Nižňanský, Denisa Osinová, Roman Kuruc, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15619-15619
Open Access | Times Cited: 22
Nanoparticle-Based Combination Therapy for Ovarian Cancer
Yingli Wu, Yu Yang, Xiaolin Lv, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1965-1987
Open Access | Times Cited: 12
Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells
Heming Zhao, Liming Gong, Hao Wu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1874-1874
Open Access | Times Cited: 12
Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors
Xin Yang, Yifan Wang, Si Chen, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7051-7069
Open Access | Times Cited: 27
A Nanosized Codelivery System Based on Intracellular Stimuli-Triggered Dual-Drug Release for Multilevel Chemotherapy Amplification in Drug-Resistant Breast Cancer
Yufan Guo, Shuo Liu, Fazhen Luo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 422-422
Open Access | Times Cited: 18
The prognostic gene CRABP2 affects drug sensitivity by regulating docetaxel-induced apoptosis in breast invasive carcinoma: A pan-cancer analysis
Shuangshuang Zeng, Zhijie Xu, Qiuju Liang, et al.
Chemico-Biological Interactions (2023) Vol. 373, pp. 110372-110372
Closed Access | Times Cited: 11
Therapeutic potential and industrial applications of Terminalia arjuna bark
Vikas Kumar, Nitin Sharma, Rakshandha Saini, et al.
Journal of Ethnopharmacology (2023) Vol. 310, pp. 116352-116352
Closed Access | Times Cited: 11

Scroll to top